GMVRX
Price
$19.20
Change
+$0.39 (+2.07%)
Updated
Jun 2 closing price
Net Assets
151.97M
VEMPX
Price
$448.42
Change
+$4.75 (+1.07%)
Updated
Jun 2 closing price
Net Assets
89.86B
Interact to see
Advertisement

GMVRX vs VEMPX

Header iconGMVRX vs VEMPX Comparison
Open Charts GMVRX vs VEMPXBanner chart's image
GMVRX vs VEMPX Comparison Chart in %
View a ticker or compare two or three
VS
GMVRX vs. VEMPX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMVRX is a StrongBuy and VEMPX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMPX has more cash in the bank: 89.9B vs. GMVRX (152M). VEMPX pays higher dividends than GMVRX: VEMPX (1.03) vs GMVRX (0.00). GMVRX was incepted earlier than VEMPX: GMVRX (12 years) vs VEMPX (15 years). GMVRX (1.70) is less costly to investors than VEMPX (0.04). GMVRX is a more actively managed with annual turnover of: 100.00 vs. VEMPX (12.00). GMVRX has a lower initial minimum investment than VEMPX: GMVRX (0) vs VEMPX (100000000). VEMPX annual gain was more profitable for investors over the last year : 29.45 vs. GMVRX (22.30). VEMPX return over 5 years is better than : 31.89 vs. GMVRX (11.31).
GMVRXVEMPXGMVRX / VEMPX
Total Expense Ratio1.420.044,057%
Annual Report Gross Expense Ratio1.700.044,857%
Fund Existence12 years15 years-
Gain YTD15.89613.454118%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets152M89.9B0%
Annual Yield % from dividends0.001.03-
Returns for 1 year22.3029.4576%
Returns for 3 years38.2466.9957%
Returns for 5 years11.3131.8935%
Returns for 10 years79.92184.5343%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHSRX54.00N/A
N/A
Putnam Global Health Care R
GCTAX58.28N/A
N/A
Goldman Sachs US Tax-Managed Eq A
RFNAX104.67N/A
N/A
American Funds Fundamental Invs R1
DTCYX21.45N/A
N/A
BNY Mellon Sust US Equity Y
LVFLX15.88N/A
N/A
Lord Abbett Focused Large Cap Value R6